Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Securigera varia
Légume européen utilisé avec prudence en médecine populaire pour les troubles cardiaques ; contient du coronillon toxique.
Coronilla varia (Securigera varia) is a European legume historically used in folk medicine for cardiac conditions, but its use is severely limited due to the presence of toxic cardiotonic glycosides such as coronillin. Despite its potential for cardiac glycoside research, the plant's narrow therapeutic index and high toxicity preclude any unsupervised use. Modern investigations focus on its bioactive compounds, including flavonoids and saponins, but clinical applications remain experimental.
Coronillin, a cardiac glycoside, inhibits the Na+/K+-ATPase pump, leading to increased intracellular calcium and enhanced myocardial contractility, similar to digitalis. Flavonoids and saponins may contribute antioxidant and anti-inflammatory effects, but these are overshadowed by the risk of severe cardiac toxicity. The narrow therapeutic window and potential for arrhythmias limit any practical therapeutic use.
Légume européen utilisé avec prudence en médecine populaire pour les troubles cardiaques ; contient du coronillon toxique.
Coronilla varia (Securigera varia) is a European legume historically used in folk medicine for cardiac conditions, but its use is severely limited due to the presence of toxic cardiotonic glycosides such as coronillin. Despite its potential for cardiac glycoside research, the plant's narrow therapeutic index and high toxicity preclude any unsupervised use. Modern investigations focus on its bioactive compounds, including flavonoids and saponins, but clinical applications remain experimental.
Coronillin, a cardiac glycoside, inhibits the Na+/K+-ATPase pump, leading to increased intracellular calcium and enhanced myocardial contractility, similar to digitalis. Flavonoids and saponins may contribute antioxidant and anti-inflammatory effects, but these are overshadowed by the risk of severe cardiac toxicity. The narrow therapeutic window and potential for arrhythmias limit any practical therapeutic use.